Skip to main content
Clinical Trials/ACTRN12622000696796
ACTRN12622000696796
Completed
未知

Evaluation of the synergistic effect of a new probiotic concept and octacosanol in the treatment of obesity and associated comorbidities in overweight and obese women

Faculty of Pharmacy, University of Belgrade0 sites55 target enrollmentStarted: May 13, 2022Last updated:

Overview

Phase
未知
Status
Completed
Sponsor
Faculty of Pharmacy, University of Belgrade
Enrollment
55

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 50 Years (—)
Sex
Female

Inclusion Criteria

  • Overweight and obese women (body mass index \> 25 kg/m^2\) with or without other comorbidities (hypertension, dyslipidemia,hyperglycemia and/or insulin resistance)

Exclusion Criteria

  • Chronic disease of the kidneys, thyroid gland and gastrointestinal tract (Crohn's disease, ulcerative colitis)
  • Taking antibiotic therapy in the last month
  • Age under 18 years
  • Taking probiotic and/or prebiotic dietary supplements
  • Hypersensitivity/intolerance to any ingredient of the product
  • Pregnancy or breast\-feeding

Investigators

Sponsor
Faculty of Pharmacy, University of Belgrade

Similar Trials